FDA NDC Directory · JSON-LD · Markdown

Busulfan

NDC 25021-241 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Labeler / ManufacturerSagent Pharmaceuticals
Marketing categoryAbbreviated NDA (generic) · App ANDA207050
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsBUSULFAN (6 mg/mL)
Marketing started20170515
Package count1

External sources

Source: openFDA. Public-domain (CC0).